References
- Stoudemire A, Cotanch P, Laszlo J. Recent advances in the pharmacologic and behavioral management of chemotherapy-induced emesis. Arch Intern Med 1984; 144: 1029–1033
- Gralla RJ, Itri LM, Pisko SE. Antiemetic efficacy of high-dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981; 305: 905–909
- Grunberg SM, Gala KV, Lampenfeld M. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. J Clin Oncol 1984; 2: 782–787
- Carr BI, Bertrand M, Browning S. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: A prospective, randomized, double-blind study. J Clin Oncol 1985; 3: 1127–1132
- Kris MG, Gralla RJ, Tyson LB. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metclopramide, dexamethasone, and diphenhydramine. Cancer 1985; 55: 527–534
- Roche H, Hyman G, Nahas G. Comparative effects of i.v. administered alizapride and prochlorperazine in cisplatin induced emesis. Cancer Invest 1987; 5: 2
- Zambetti M, Bajetta E, Bidoli P. Antiemetic activity of metoclopramide versus alizapride during cancer chemotherapy. Tumori 1985; 71: 609–614
- Sailer R, Hellenbrecht D. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis. Cancer Treat Rep 1985; 69: 1301–1303
- Joss RA, Galeazzi RL, Bischoff AK. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: A prospective, randomized, double-blind trial. Clin Pharmacol Ther 1986; 39: 619–624
- Grunberg SM, Ehler E, McDermed JE. Phase I study of an extended regimen of oral metoclopramide. Proc ASCO 1986; 5: 261
- Kris MG, Gralla RJ, Clark RA. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 1985; 3: 1379–1384
- Strum S, McDermed J, Abrahano-Umall R. Management of cisplatin-induced delayed-onset nausea and vomiting: Preliminary results with 2 drug regimens. Proc ASCO 1985; 4: 263
- Clark R, Kris M, Tyson L. Antiemetic trials to control delayed vomiting following high-dose cisplatin. Proc ASCO 1986; 5: 257
- Moher D, Arthur AZ, Pater JL. Anticipatory nausea and/or vomiting. Cancer Treat Rev 1984; 11: 257–264
- Bernstein IL. Physiological and psychological mechanisms of cancer anorexia. Cancer Res 1982; 42: 715s–720s